Cardiovascular Risk Factors Mediate the Long-Term Maternal Risk Associated With Hypertensive Disorders of Pregnancy

Jennifer J Stuart, Lauren J Tanz, Eric B Rimm, Donna Spiegelman, Stacey A Missmer, Kenneth J Mukamal, Kathryn M Rexrode, Janet W Rich-Edwards, Jennifer J Stuart, Lauren J Tanz, Eric B Rimm, Donna Spiegelman, Stacey A Missmer, Kenneth J Mukamal, Kathryn M Rexrode, Janet W Rich-Edwards

Abstract

Background: Hypertensive disorders of pregnancy (HDP), including gestational hypertension and preeclampsia, are associated with an increased risk of CVD.

Objectives: The purpose of this study was to evaluate associations between HDP and long-term CVD and identify the proportion of the association mediated by established CVD risk factors.

Methods: Parous participants without CVD in the Nurses' Health Study II (n = 60,379) were followed for incident CVD from first birth through 2017. Cox proportional hazards models estimated HRs and 95% CIs for the relationship between HDP and CVD, adjusting for potential confounders, including prepregnancy body mass index, smoking, and parental history of CVD. To evaluate the proportion of the association jointly accounted for by chronic hypertension, hypercholesterolemia, type 2 diabetes, and changes in body mass index, we used the difference method.

Results: Women with HDP in first pregnancy had a 63% higher rate of CVD (95% CI: 1.37-1.94) compared with women with normotensive pregnancies. This association was mediated by established CVD risk factors (proportion mediated = 64%). The increased rate of CVD was higher for preeclampsia (HR: 1.72; 95% CI: 1.42-2.10) than gestational hypertension (HR: 1.41; 95% CI: 1.03-1.93). Established CVD risk factors accounted for 57% of the increased rate of CVD for preeclampsia but 84% for gestational hypertension (both P < 0.0001).

Conclusions: Established CVD risk factors arising after pregnancy explained most (84%) of the increased risk of CVD conferred by gestational hypertension and 57% of the risk among women with preeclampsia. Screening for chronic hypertension, hypercholesterolemia, type 2 diabetes, and overweight/obesity after pregnancy may be especially helpful in CVD prevention among women with a history of HDP.

Keywords: cardiovascular disease; cardiovascular disease risk factors; preeclampsia; pregnancy.

Conflict of interest statement

Funding Support and Author Disclosures This research was funded by the following grants from the National Institutes of Health: U01 CA176726, R01 HL088521, R01 HL34594, and U01 HL145386. This work was supported by awards from the American Heart Association (12PRE9110014, 13GRNT17070022). Dr Stuart was supported by Training Grant T32HL098048 from the National Heart, Lung, and Blood Institute and by Training Grant T32HD060454 from the National Institute of Child Health and Human Development. Dr Tanz was supported by F31HL131222 from the National Heart, Lung, and Blood Institute under the Ruth L. Kirschstein National Research Service Award. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.

Copyright © 2022 The Authors. Published by Elsevier Inc. All rights reserved.

Figures

Figure 1:. Flow diagram for the primary,…
Figure 1:. Flow diagram for the primary, mediation, and secondary analyses.
* Women reporting chronic hypertension within one year after first birth (n=115) were excluded to prevent misclassification of exposure (undetected chronic hypertension before pregnancy may be incorrectly captured as incident chronic hypertension directly following pregnancy) and since the exact date of diagnosis was unknown, which prevented definitive determination as to whether the chronic hypertension arose before, during, or after pregnancy.
Figure 2:. Nurses’ Health Study II data…
Figure 2:. Nurses’ Health Study II data collection timeline and analytic follow-up.
Ascertainment of exposure and assignment of pre-pregnancy covariate information for participants with their first birth before cohort enrollment and for those with their first birth during active follow-up.
Figure 3:. Multivariable-adjusted cumulative incidence of cardiovascular…
Figure 3:. Multivariable-adjusted cumulative incidence of cardiovascular disease.
Curves were obtained at the mean and mode values of the following continuous and categorical covariates, respectively: age at first birth, age at NHSII enrollment, race/ethnicity, parental education, physical activity at ages 18–22, parental history of CVD

Central Illustration:. Differential associations by hypertensive disorder…

Central Illustration:. Differential associations by hypertensive disorder of pregnancy and cardiovascular disease subtypes.

Hazard ratios…

Central Illustration:. Differential associations by hypertensive disorder of pregnancy and cardiovascular disease subtypes.
Hazard ratios and 95% confidence intervals (CI) were obtained from fully adjusted Cox proportional hazards models (Table 2, Model 2). The overall association between having a hypertensive disorder in first pregnancy and long-term maternal cardiovascular disease appeared to be driven by underlying associations between preeclampsia and coronary artery disease and between gestational hypertension and stroke.
Central Illustration:. Differential associations by hypertensive disorder…
Central Illustration:. Differential associations by hypertensive disorder of pregnancy and cardiovascular disease subtypes.
Hazard ratios and 95% confidence intervals (CI) were obtained from fully adjusted Cox proportional hazards models (Table 2, Model 2). The overall association between having a hypertensive disorder in first pregnancy and long-term maternal cardiovascular disease appeared to be driven by underlying associations between preeclampsia and coronary artery disease and between gestational hypertension and stroke.

References

    1. Grandi SM, Filion KB, Yoon S et al. Cardiovascular Disease-Related Morbidity and Mortality in Women With a History of Pregnancy Complications. Circulation 2019;139:1069–1079.
    1. Wang YX, Arvizu M, Rich-Edwards JW et al. Hypertensive Disorders of Pregnancy and Subsequent Risk of Premature Mortality. J Am Coll Cardiol 2021;77:1302–1312.
    1. Cirillo PM, Cohn BA. Pregnancy complications and cardiovascular disease death: 50-year follow-up of the Child Health and Development Studies pregnancy cohort. Circulation 2015;132:1234–42.
    1. Mannisto T, Mendola P, Vaarasmaki M et al. Elevated blood pressure in pregnancy and subsequent chronic disease risk. Circulation 2013;127:681–90.
    1. Leon LJ, McCarthy FP, Direk K et al. Preeclampsia and Cardiovascular Disease in a Large UK Pregnancy Cohort of Linked Electronic Health Records: A CALIBER Study. Circulation 2019;140:1050–1060.
    1. Mongraw-Chaffin ML, Cirillo PM, Cohn BA. Preeclampsia and cardiovascular disease death: prospective evidence from the child health and development studies cohort. Hypertension 2010;56:166–71.
    1. Bergman L, Nordlof-Callbo P, Wikstrom AK et al. Multi-Fetal Pregnancy, Preeclampsia, and Long-Term Cardiovascular Disease. Hypertension 2020;76:167–175.
    1. Garovic VD, White WM, Vaughan L et al. Incidence and Long-Term Outcomes of Hypertensive Disorders of Pregnancy. J Am Coll Cardiol 2020;75:2323–2334.
    1. de Havenon A, Delic A, Stulberg E et al. Association of Preeclampsia With Incident Stroke in Later Life Among Women in the Framingham Heart Study. JAMA Netw Open 2021;4:e215077.
    1. Stuart JJ, Tanz LJ, Missmer SA et al. Hypertensive Disorders of Pregnancy and Maternal Cardiovascular Disease Risk Factor Development: An Observational Cohort Study. Ann Intern Med 2018;169:224–232.
    1. Grundy SM, Stone NJ, Bailey AL et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol 2018.
    1. Haug EB, Horn J, Markovitz AR et al. Association of Conventional Cardiovascular Risk Factors With Cardiovascular Disease After Hypertensive Disorders of Pregnancy: Analysis of the Nord-Trondelag Health Study. JAMA Cardiol 2019;4:628–635.
    1. Honigberg MC, Zekavat SM, Aragam K et al. Long-Term Cardiovascular Risk in Women With Hypertension During Pregnancy. J Am Coll Cardiol 2019;74:2743–2754.
    1. Mosca L, Benjamin EJ, Berra K et al. Effectiveness-based guidelines for the prevention of cardiovascular disease in women−-2011 update: a guideline from the american heart association. Circulation 2011;123:1243–62.
    1. Stuart JJ, Gray KJ, Rich-Edwards J, Roberts JM. Epidemiology of Hypertensive Disorders in Pregnancy. In: Taylor RN, Conrad KP, Davidge ST, Staff AC, Roberts JM, editors. Chesley’s Hypertensive Disorders in Pregnancy. 5th ed. San Diego: Elseview Science & Technology, 2021:27.
    1. Wilcox AJ, Gladen BC. Spontaneous abortion: the role of heterogeneous risk and selective fertility. Early Human Development 1982;7:165–178.
    1. Alpert JS, Thygesen K, Antman E, Bassand JP. Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 2000;36:959–69.
    1. World Health Organization. Ischemic Heart Disease Registers: Report of the Fifth Working Group. Copenhagen: World Health Organization. 1971.
    1. Walker AE, Robins M, Weinfeld FD. The National Survey of Stroke. Clinical findings. Stroke 1981;12:I13–44.
    1. Chiuve SE, Fung TT, Rimm EB et al. Alternative dietary indices both strongly predict risk of chronic disease. J Nutr 2012;142:1009–18.
    1. National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 1979;28:1039–57.
    1. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997;20:1183–97.
    1. Rich-Edwards JW, Colditz GA, Stampfer MJ et al. Birthweight and the risk for type 2 diabetes mellitus in adult women. Ann Intern Med 1999;130:278–84.
    1. Forman JP, Curhan GC, Taylor EN. Plasma 25-hydroxyvitamin D levels and risk of incident hypertension among young women. Hypertension 2008;52:828–32.
    1. Colditz GA, Martin P, Stampfer MJ et al. Validation of questionnaire information on risk factors and disease outcomes in a prospective cohort study of women. Am J Epidemiol 1986;123:894–900.
    1. Manson JE, Colditz GA, Stampfer MJ et al. A prospective study of maturity-onset diabetes mellitus and risk of coronary heart disease and stroke in women. Arch Intern Med 1991;151:1141–7.
    1. Durrleman S, Simon R. Flexible regression models with cubic splines. Stat Med 1989;8:551–61.
    1. Govindarajulu US, Spiegelman D, Thurston SW, Ganguli B, Eisen EA. Comparing smoothing techniques in Cox models for exposure-response relationships. Stat Med 2007;26:3735–52.
    1. VanderWeele TJ. Causal mediation analysis with survival data. Epidemiology 2011;22:582–5.
    1. VanderWeele TJ. Explanation in Causal Inference: Methods for Mediation and Interaction. New York: Oxford University Press, 2015.
    1. Hertzmark E PM, Spiegelman D. The SAS Mediate Macro. , 2012.
    1. Lin DY, Fleming TR, De Gruttola V. Estimating the proportion of treatment effect explained by a surrogate marker. Stat Med 1997;16:1515–27.
    1. Stuart JJ, Tanz LJ, Cook NR et al. Hypertensive Disorders of Pregnancy and 10-Year Cardiovascular Risk Prediction. J Am Coll Cardiol 2018;72:1252–1263.
    1. Wikstrom AK, Haglund B, Olovsson M, Lindeberg SN. The risk of maternal ischaemic heart disease after gestational hypertensive disease. BJOG 2005;112:1486–91.
    1. Tsao CW, Aday AW, Almarzooq ZI et al. Heart Disease and Stroke Statistics-2022 Update: A Report From the American Heart Association. Circulation 2022;145:e153–e639.
    1. Ying W, Catov JM, Ouyang P. Hypertensive Disorders of Pregnancy and Future Maternal Cardiovascular Risk. J Am Heart Assoc 2018;7:e009382.
    1. Zoet GA, Benschop L, Boersma E et al. Prevalence of Subclinical Coronary Artery Disease Assessed by Coronary Computed Tomography Angiography in 45- to 55-Year-Old Women With a History of Preeclampsia. Circulation 2018;137:877–879.
    1. Countouris ME, Villanueva FS, Berlacher KL, Cavalcante JL, Parks WT, Catov JM. Association of Hypertensive Disorders of Pregnancy With Left Ventricular Remodeling Later in Life. J Am Coll Cardiol 2021;77:1057–1068.
    1. Ives CW, Sinkey R, Rajapreyar I, Tita ATN, Oparil S. Preeclampsia-Pathophysiology and Clinical Presentations: JACC State-of-the-Art Review. J Am Coll Cardiol 2020;76:1690–1702.
    1. Bokslag A, Franssen C, Alma LJ et al. Early-onset preeclampsia predisposes to preclinical diastolic left ventricular dysfunction in the fifth decade of life: An observational study. Plos One 2018;13.
    1. AbdelWahab MA, Farrag HM, Saied CE. 24-Hour blood pressure variability as a predictor of short-term echocardiographic changes in normotensive women with past history of preeclampsia/eclampsia. Pregnancy Hypertens 2018;13:72–78.
    1. ACOG Practice Bulletin. Clinical Management Guidelines for Obstetrician-Gynecologists. Gestational Hypertension and Preeclampsia. Obstet Gynecol 2019;133:e1–e25.
    1. Parikh NI, Gonzalez JM, Anderson CAM et al. Adverse Pregnancy Outcomes and Cardiovascular Disease Risk: Unique Opportunities for Cardiovascular Disease Prevention in Women: A Scientific Statement From the American Heart Association. Circulation 2021;143:e902–e916.
    1. Magnussen EB, Vatten LJ, Lund-Nilsen TI, Salvesen KA, Davey Smith G, Romundstad PR. Prepregnancy cardiovascular risk factors as predictors of pre-eclampsia: population based cohort study. BMJ 2007;335:978.
    1. Harskamp RE, Zeeman GG. Preeclampsia: at risk for remote cardiovascular disease. Am J Med Sci 2007;334:291–5.
    1. Rodie VA, Freeman DJ, Sattar N, Greer IA. Pre-eclampsia and cardiovascular disease: metabolic syndrome of pregnancy? Atherosclerosis 2004;175:189–202.
    1. Rich-Edwards JW, McElrath TF, Karumanchi SA, Seely EW. Breathing life into the lifecourse approach: pregnancy history and cardiovascular disease in women. Hypertension 2010;56:331–4.
    1. Sattar N, Greer IA. Pregnancy complications and maternal cardiovascular risk: opportunities for intervention and screening? Bmj 2002;325:157–60.

Source: PubMed

3
Abonnere